<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02091180</url>
  </required_header>
  <id_info>
    <org_study_id>2012069</org_study_id>
    <nct_id>NCT02091180</nct_id>
  </id_info>
  <brief_title>Mannitol Improves Cerebral Oxygen Saturation</brief_title>
  <official_title>Effect of Preoperative Mannitol Infusion on Cerebral Oxygen Saturation and Patients' Recovery After Laparoscopic Cholecystectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dammam University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dammam University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Decreased cerebral oxygen saturation (rSO2) was reported to occur during insufflation for
      laparoscopic procedures due to increased Intracranial pressure (ICP) with resultant decrease
      in cerebral perfusion pressure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Forty patients scheduled for laparoscopic cholecystectomy will be enrolled in this double
      blind, randomized controlled study. Patients will receive either 0.5g/kg of 20% intravenous
      (i.v.) mannitol infusion over 10 minutes immediately before induction of anesthesia (group M)
      or an equal volume of 0.9% normal saline instead (group C). Primary outcome measure is rSO2.
      Secondary outcome variables include extubation time, clinical assessment of consciousness
      recovery using the modified Observer's assessment of alertness/sedation scale (OAA/S) and the
      mini-mental state examination (MMSE) for cognitive evaluation after recovery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">February 2014</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>rSO2</measure>
    <time_frame>participants will be followed for the duration of surgery, an expected average of 1 hour</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>extubation time</measure>
    <time_frame>intraoperative</time_frame>
    <description>time from end of anesthesia to fulfilling extubation criteria</description>
  </secondary_outcome>
  <other_outcome>
    <measure>OAA/S</measure>
    <time_frame>after surgery 30 minutes.</time_frame>
    <description>alertness/sedation scale</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Mannitol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive 0.5g/kg of 20% intravenous (i.v.) mannitol infusion over 10 minutes immediately before induction of anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will receive normal saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mannitol</intervention_name>
    <description>0.5g/kg of 20% intravenous (i.v.) mannitol infusion over 10 minutes immediately before induction of anesthesia</description>
    <arm_group_label>Mannitol</arm_group_label>
    <other_name>mannite or manna sugar</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Saline infusion</description>
    <arm_group_label>Control</arm_group_label>
    <other_name>Saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologists physical status I or II

          -  aged between 25 and 50 years

          -  with a body mass index (BMI) 22-34 kg/m2

        Exclusion Criteria:

          -  obstructive or restrictive pulmonary disease

          -  cardiac dysfunction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hany A Mowafi, MD</last_name>
    <role>Study Director</role>
    <affiliation>Imam Abdulrahman Bin Faisal University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Anesthesia Department, University of Dammam</name>
      <address>
        <city>Al-Khobar</city>
        <state>EP</state>
        <zip>31952</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>King Fahd Hosital of the University</name>
      <address>
        <city>Al-Khobar</city>
        <state>EP</state>
        <zip>31952</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Saudi Arabia</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 15, 2014</study_first_submitted>
  <study_first_submitted_qc>March 18, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 19, 2014</study_first_posted>
  <last_update_submitted>March 18, 2014</last_update_submitted>
  <last_update_submitted_qc>March 18, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 19, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dammam University</investigator_affiliation>
    <investigator_full_name>Hany A. Mowafi</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>Anesthesia</keyword>
  <keyword>Recovery</keyword>
  <keyword>laparoscopy</keyword>
  <keyword>cholecystectomy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mannitol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

